NAVB - Navidea Biopharmaceuticals, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts2022
Avg. Estimate-0.120-0.61-0.52
Low Estimate-0.150-0.74-0.75
High Estimate-0.090-0.49-0.3
Year Ago EPSN/AN/AN/A-0.61
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts2022
Avg. Estimate150kN/A650k1.15M
Low EstimateN/AN/A400kN/A
High Estimate300kN/A900k2.3M
Year Ago SalesN/AN/A847k650k
Sales Growth (year/est)N/AN/A-23.30%76.90%
Earnings HistoryInvalid DateInvalid Date6/29/20199/29/2019
EPS Est.N/AN/A-0.15-0.17
EPS ActualN/AN/A-0.24-0.17
DifferenceN/AN/A-0.090
Surprise %N/AN/A-60.00%0.00%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.120-0.61-0.52
7 Days Ago-0.120-0.61-0.52
30 Days Ago-0.150-0.74-0.75
60 Days Ago-0.150-0.74-0.75
90 Days Ago-0.150-0.74-0.75
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNAVBIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.01
Next Qtr.N/AN/AN/A0.06
Current YearN/AN/AN/A-0.03
Next Year14.80%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A